Live data — every record is aggregated from real public sources. VialGrade never sells; it links out to the vendor.
VialGrade
All compounds
Antimicrobial peptide
Live data

LL-37

Immune & thymicRecovery & healing

A human antimicrobial peptide studied in immune-defense and wound research.

CathelicidinhCAP18 fragment

Get told when a price moves or a lab test changes.

Observed median price

$78

0.0 % · 30d
Every observation
DateObserved
$64.95
$104.37
$45.00
$58.50
$63.00
$63.00
$63.00
$63.98
$64.95
$71.99
$71.99
$71.99
$71.99
$71.99
$71.99
$71.99
$71.99
$71.99
$71.99
$71.99
$71.99
$71.99
$71.99
$75.00
$75.00
$75.00
$75.00
$71.99
$71.99
$71.99
$71.99
$71.99
$71.99
$82.00
$75.00
$78.00
$78.00
$78.00

Median of 8 listings' 30-day changes; 9 excluded for insufficient history.

17

Active listings

1 · 99.3%

Independent lab tests

$45–$720

Observed price range

3

Known aliases

Read from the certificate, not re-measured by VialGrade. Purity is not a grade. Purity vs grade

Understand this compound

What is LL-37?

Preclinical / animal onlya.k.a. Cathelicidin, hCAP-18 (precursor form)

Your body's own built-in antibiotic — a molecule the immune system uses to punch holes in microbes and rally immune cells. Studied for infections and wound healing.

Immune & thymicRecovery & healing
⚠

Good to know: Native LL-37 is cytotoxic and hemolytic at higher concentrations and degrades rapidly in vivo, which is why most therapeutic development uses modified analogs rather than the native peptide.

How does LL-37 work?

The science

The only human cathelicidin antimicrobial peptide; it disrupts microbial membranes directly and also signals through the formyl peptide receptor FPRL-1/FPR2 to recruit and activate immune cells.

Mechanism of action from published research — how the molecule behaves, not a claim about any product or any human-use effect.

What is LL-37 researched for?

Studied for broad-spectrum antimicrobial, antiviral, wound-healing, and immunomodulatory applications.

  • Immune & thymicStudied in immune-modulation and thymic-function research.
  • Recovery & healingStudied in tissue-repair research — tendon, ligament, muscle, and wound-healing models.
How far has the research gone?

Preclinical / animal research — extensively studied in vitro and in animal wound/infection models, but poor stability and toxicity have kept it from clinical translation.

Where the science stands — an approved drug is not the same as the research-grade material a vendor sells, which is unregulated regardless.

What should I check before buying?
  • Independent purity. Look for a third-party COA (Janoshik or MZ) showing a measured purity — not just a number the vendor typed.
  • Batch match. The strongest evidence is a certificate for the exact batch you’ll receive, attributed to this vendor — check the cross-verification on the listing.
  • Vendor reputation. See how the vendor is talked about in the community before trusting a new name.

Research context only — VialGrade never gives dosing, medical, or human-use guidance.

Current market

The LL-37 market

Every LL-37 listing we track — 17 in all. The standout picks first where the evidence supports them, then the full table, ranked by what a milligram really costs wherever the vendor published a strength we can read.

Open full market

Compare by real cost

Every LL-37 listing, cheapest per mg first

Sticker prices hide the size, so listings are ranked by what a milligram actually costs — with independently tested purity where it exists. All 17 are here: the last 4 are listings whose vendor never published a strength we can read, so they have no per-mg figure to sort on.

#VendorSizePricePer mgTested purityReal $/active mg
1Simple Peptide10mg total$54$5.40/mg · too cheap?—$5.44/mgbest valueView
2Ascension PeptidesUnavailable10mg total$78$7.80/mg—$7.85/mgView
3Ez Peptides10mg total$78$7.80/mg—$7.85/mgView
4Ion PeptideUnavailable5mg total$45$9.00/mg—$9.06/mgView
5Modern Aminos5mg total$47$9.40/mg—$9.46/mgView
6Chameleon Peptides50mg total10-vial kit each$490$9.80/mg—$9.87/mgView
7Swiss Chems5mg total$72$14.4/mg—$14.5/mgView
8Swiss ChemsUnavailable50mg totalLL-37 (CAP-18) 5mg: KIT (10 vials) each$720$14.4/mg—$14.5/mgView
9Biotech Peptides5mg total$86$17.2/mg—$17.3/mgView
10Core Peptides5mg total$89$17.8/mg—$17.9/mgView

Open the full LL-37 market

Real $/active mg divides the price-per-mg by the measured purity — the honest cost of the actual peptide, so a 90%-pure vial isn’t compared as if it were 99%. Too cheap? flags a listing far below the market rate — often underdosing or a fake, not a deal. The crown marks the cheapest non-outlier; best value marks the lowest real cost per active mg. A vendor shown as Unavailable or Low stock is priced here but not currently buyable.

Independent testing

LL-37 — independent lab tests

Real, publicly verifiable third-party tests. Purity is read from the certificate itself. A test reflects one lab’s result for one submitted batch — not a guarantee that every vial matches.

How does this data get here?

Every record below is a real certificate of analysis, gathered two ways: from the public verification feeds that independent labs (like Janoshik) publish, and from the certificates vendors post on their own product pages. We open each certificate document and read the measured purity, content, batch, and date directly off it — a scraper can’t read a number printed inside an image, so this is done by machine vision, then recorded here with a link back to the original.

Nothing here is typed in by a vendor or invented by us. Where a certificate is missing, we say so rather than filling the gap.

We re-check the lab feed, too. A “still listed” tag means the certificate is currently public in Janoshik’s database — we re-verify against the live feed and stamp the date. If a cert is later pulled, the tag flips. It’s a freshness check on the same source, not a second independent opinion.

What a certificate does & doesn’t prove

Three different questions. Purity (“how clean?”), identity (“is it the right molecule?”, a mass-spec test), and content (“did I get the labeled mg?”) are separate. A vial can be 99% pure and still be the wrong peptide, or the right peptide underdosed. We flag the measured dose against the label above; underdosing is the most common real fraud.

Who submitted the sample matters. Most of these are vendor-submitted — the seller chose which vial to send, so one good certificate doesn’t prove every batch is the same. The gold standard is a blind test, where a buyer sends a vial they bought as a normal customer. Same label doesn’t prove same product; same batch number doesn’t prove same batch.

99.3%

highest tested purity

CertificateManufacturerBatchPurityContent / doseLab
PeptideGurus3rd June 202699.32%7.83/7mg · fullJanoshik Analytical Still listed Verify

Tested batches

Batch test records for LL-37

The full test history for one batch — who picked the sample, who tested it, and what came back. It describes the vials that were tested, never every vial they sold.

All batch records

What the research says

Scientific evidence & regulatory status

What the published literature actually shows about LL-37 — separate from any vendor’s marketing. Each finding links to its paper. This is education, not medical or dosing advice.

Regulatory status

No FDA-approved drug

An endogenous human cathelicidin peptide; synthetic LL-37 is not FDA-approved and remains investigational. FDA placed cathelicidin LL-37 in category 2 (significant safety risks) for compounding, citing immunogenicity risk by some routes and peptide-related impurities; the nomination was later withdrawn.

Honest overall read

LL-37 is a natural human innate-immunity peptide whose early human data are limited to a small Phase 1 melanoma trial; it showed dermatologic toxicity and has paradoxical cancer-promoting effects in some tissues, so it is far from a validated therapeutic.

Human studyDermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma (Journal of Cutaneous Pathology, 2018)

A Phase 1 trial delivered weekly intratumoral LL-37 injections to melanoma patients; a case report from that trial documented a severe but reversible skin reaction (keratoacanthoma-like squamous proliferation and lichenoid dermatitis) that resolved within two months of stopping therapy.

Documented dermatologic toxicity in a trial participant; overall efficacy results remain largely unpublished.

read the source
ReviewRoles and Mechanisms of Human Cathelicidin LL-37 in Cancer (Cellular Physiology and Biochemistry, 2018)

A review summarizes evidence that LL-37 has context-dependent, sometimes opposite roles in cancer, promoting tumor growth and invasion in some cancers while being suppressive in others.

LL-37 can be pro-tumorigenic depending on tissue, a genuine concern that undercuts blanket 'immune-boosting' or 'anti-cancer' marketing claims.

read the source
US legal status

Research-use-only — not FDA-approved

Sold “for research use only,” this compound is not FDA-approved for human use and has not been evaluated for safety, purity, or sterility in people. It is generally not a scheduled controlled substance, so buying it as a research chemical is typically not itself a drug crime — but marketing or using it as a drug is not lawful, and it is not a dietary supplement.

Read the full US law →

General information, not legal or medical advice. VialGrade sells nothing and encourages no human use.

Research notes aren’t product proof

Research summaries describe published literature and market data only. They do not establish the identity, quality, safety, or legal status of any listed physical product.